Sensei Biotherapeutics Completes Faeth Acquisition, Secures $200M Financing
Sensei Biotherapeutics (NASDAQ:SNSE) has successfully completed its acquisition of Faeth Therapeutics, a privately held company focused on innovative cancer therapies. This announcement was made during a recent webcast and conference…